Literature DB >> 8950995

Characterization of the PEST family protein tyrosine phosphatase BDP1.

Y W Kim1, H Wang, I Sures, R Lammers, K J Martell, A Ullrich.   

Abstract

Using a polymerase chain reaction (PCR) amplification strategy, we identified a novel protein tyrosine phosphatase (PTPase) designated Brain Derived Phosphatase (BDP1). The full length sequence encoded an open reading frame of 459 amino acids with no transmembrane domain and had a calculated molecular weight of 50 kDa. The predicted amino acid sequence contained a PEST motif and accordingly, BDP1 shared the greatest homology with members of the PTP-PEST family. When transiently expressed in 293 cells BDP1 hydrolyzed p-Nitrophenylphosphate, confirming it as a functional protein tyrosine phosphatase. Northern blot analysis indicated that BDP1 was expressed not only in brain, but also in colon and several different tumor-derived cell lines. Furthermore, BDP1 was found to differentially dephosphorylate autophosphorylated tyrosine kinases which are known to be overexpressed in tumor tissues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950995

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.

Authors:  B Wang; S Lemay; S Tsai; A Veillette
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase.

Authors:  S Spencer; D Dowbenko; J Cheng; W Li; J Brush; S Utzig; V Simanis; L A Lasky
Journal:  J Cell Biol       Date:  1997-08-25       Impact factor: 10.539

3.  Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364.

Authors:  Laura Schramm
Journal:  Diagnostics (Basel)       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.